Studies on the formulation optimization and controlled ionic gelation of chitosan nanoparticles using TPP-HP-β-CD inclusion complex

Yıl 2020, Cilt: 50 Sayı: 1, 54 - 59, 01.04.2020

N. Başaran Mutlu Ağardan

Öz

Background and Aims: Ionic gelation strategy is the most common method used for the preparation of chitosan nanoparticles to obtain controlled drug delivery. Although it is a convenient and easy method, it is highly related with particle aggregation, high polidispersity index and insufficient physical/chemical stability. The aim of this study was the development of chitosan nanoparticles using tripolyphosphate-hydroxy propyl β-cyclodextrin or tripolyphosphate-sulfobutyl ether β-cyclodextrin inclusion complex as an alternative to TPP, and hence to increase physical stability, reduce polidispersity index and develop a stable nanocarrier for drug delivery purposes. Methods: The nanoparticles were prepared with the ionic gelation technique. The effects of chitosan percent, pH, and chitosan/tripolyphosphate ratio were investigated to find out the optimum nanoparticles in terms of particle size, polidispersity index and zeta potential. After determining the conditions for the tripolyphosphate-chitosan nanoparticles, the nanoparticles were prepared using tripolyphosphate-hydroxypropyl β-cyclodextrin or tripolyphosphate-sulfobutyl ether β-cyclodextrin to make a comparison with the nanoparticles which were prepared using tripolyphosphate. Results: The chitosan/tripolyphosphate-hydroxypropyl β-cyclodextrin nanoparticles were successfully formulated with 178 ± 84.1 nm particle size, 0.310±0.0134 PDI, 31.2±4.68 mV zeta potential. The interday changes in the measured characteristics were minimized for chitosan/tripolyphosphate-hydroxypropyl β-cyclodextrin nanoparticles as intended. Conclusion: CS/TPP-HP-β-CD nanoparticle formulation with particle size below 200 nm, high zeta potential and increased physical stability nanoparticles would offer a promising approach especially for hydrophobic drugs to improve their stability, solubility, encapsulation efficiency and in vivo bioavailability.

Anahtar Kelimeler

Chitosan nanoparticles, controlled ionic gelation, cyclodextrins

Kaynakça

• • Ağardan, N. B., Değim, Z., Yılmaz, Ş., Altıntaş, L., & Topal, T. (2016). The Effectiveness of raloxifene-loaded liposomes and cochleates in breast cancer therapy. AAPS PharmSciTech, 17(4), 968– 977.
• • Agarwal M, A. M., Shrivastav, N., Pandey, S., Das, R., & Gaur, P. (2018). Preparation of Chitosan Nanoparticles and their In-vitro Characterization. International Journal of Life-Sciences Scientific Research, 4(2), 1713–1720.
• • Agnihotri, S. A., Mallikarjuna, N. N., & Aminabhavi, T. M. (2004). Recent advances on chitosan-based micro- and nanoparticles in drug delivery. Journal of Controlled Release, 100(1), 5–28.
• • Ahmed, T. A., & Aljaeid, B. M. (2016). Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery. Drug Design, Development and Therapy, 10, 483–507.
• • Calvo, P., Remuñan-López, C., Vila-Jato, J. L., & Alonso, M. J. (1997). Chitosan and Chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharmaceutical Research, 14(10), 1431–1436.
• • Crucho, C. I. C., & Barros, M. T. (2017). Polymeric nanoparticles: A study on the preparation variables and characterization methods. Materials Science and Engineering: C, 80, 771–784.
• • Elsabahy, M., & Wooley, K. L. (2012). Design of polymeric nanoparticles for biomedical delivery applications. Chemical Society Reviews, 41(7), 2545–2561. • Fulop, Z., Saokham, P., & Loftsson, T. (2014). Sulfobutylether-betacyclodextrin/chitosan nano- and microparticles and their physicochemical characteristics. International Journal of Pharmaceutics, 472(1-2), 282–287. • Grenha, A. (2012). Chitosan nanoparticles: a survey of preparation methods. Journal of Drug Targeting, 20(4), 291–300.
• • Kapor A, S. S., Nikolic, V., Cvezic, Z., & Rakic, S. (2008). DSC and XRD analysis of inclusion complexes of inclusion complexes of pharmacologically active compounds. Journal of Reseach in Physics, 32(1), 25–31.
• • Kumari, A., Yadav, S. K., & Yadav, S. C. (2010). Biodegradable polymeric nanoparticles based drug delivery systems. Colloids and Surfaces B: Biointerfaces, 75(1), 1–18.
• • Loftsson, T., Duchene, D. (2007). Cyclodextrins and their pharmaceutical applications. International Journal of Pharmaceutics, 329(1–2), 1–11.
• • Mahmoud, A. A., El-Feky, G. S., Kamel, R., & Awad, G. E. A. (2011). Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery. International Journal of Pharmaceutics, 413(1), 229–236.
• • Miecznik, P., & Kaczmarek, M. (2007). Ultrasonic investigations of inclusion complexation of α-cyclodextrin by iodide ions in pseudo-binary aqueous system. Journal of Molecular Liquids, 133(1), 120–124.
• • Mohammed, M. A., Syeda, J. T. M., Wasan, K. M., Wasan, E. K. (2017). An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery. Pharmaceutics, 9(4), 53.
• • Mutlu Ağardan, N. B., Değim, Z., & Yilmaz, Ş. (2014). Antitumoral and MMP-2 inhibition activity of raloxifene or tamoxifen loaded nanoparticles containing dimethyl-β-cyclodextrin. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 80(1), 31–36.
• • Nallamuthu, I., Devi, A., & Khanum, F. (2015). Chlorogenic acid loaded chitosan nanoparticles with sustained release property, retained antioxidant activity and enhanced bioavailability. Asian Journal of Pharmaceutical Sciences, 10(3), 203–211.
• • Ohya, Y., Shiratani, M., Kobayashi, H., & Ouchi, T. (1994). Release behavior of 5-Fluorouracil from Chitosan-Gel Nanospheres Immobilizing 5-Fluorouracil Coated with Polysaccharides and Their Cell Specific Cytotoxicity. Journal of Macromolecular Science, Part A, 31(5), 629–642.
• • Pant, A., & Negi, J. S. (2018). Novel controlled ionic gelation strategy for chitosan nanoparticles preparation using TPP-beta-CD inclusion complex. European Journal of Pharmaceutical Sciences, 112, 180–185.
• • Rizvi, S. A. A., & Saleh, A. M. (2018). Applications of nanoparticle systems in drug delivery technology. Saudi Pharmaceutical Journal : SPJ : the Official Publication of The Saudi Pharmaceutical Society, 26(1), 64–70.
• • Sreekumar, S., Goycoolea, F. M., Moerschbacher, B. M., & Rivera-Rodriguez, G. R. (2018). Parameters influencing the size of chitosanTPP nano- and microparticles. Scientific Reports, 8(1), 4695.